UnknownNCT00965809
Add on Study on Δ9-THC Treatment for Posttraumatic Stress Disorders (PTSD)
Medication studyAges 19–60Israel
Understand this study
Who could participate?
Listed age limits: 19 years to 60 years.
- Listed locations
- JerusalemSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateOctober 2009
- Recruitment status
- Unknown
- Enrollment listed in the registry
- 70
- Sponsor
- Hadassah Medical Organization
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Medication / drug, OTHER
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- Israel
- Age range
- From 19 Years to 60 Years
- Official registry ID
- NCT00965809
- Official title
Show the full official title
Double Blind, Placebo-Controlled Trial of THC as add-on Therapy for PTSD
Recruitment & locations
Status unknownJerusalem
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is Hadassah Medical Organization.
Does this study involve medication?
Yes. The study involves medication, including Tetrahydrocannabinol.
Who can participate?
Listed age limits: 19 years to 60 years.
